glp 1 and restless leg syndrome GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, Emerging Therapies Potential Use of GLP-1 and

To learn more and register, visit us on the LearnWorlds platform

Patients covered by Medicaid or Medicare, Black patients, and those who experienced gastrointestinal side effectssuch as nausea, reported in 37% of caseswere more likely to stop their medication within the first year

The key insight: discontinuation isn't binary

The need for improved therapeutics is being driven by rising awareness of obesity as a chronic illness and an increasing readiness to use pharmaceutical treatments

Applying a systems approach to thyroid physiology: Looking at the whole with a mitochondrial perspective instead of judging single TSH values or why we should know more about mitochondria to understand metabolism